Natriumcromoglicaat Allergieneusspray Htp (Sodium Cromoglicate)

Sodium cromoglicate, the active ingredient in Natriumcromoglicaat Allergieneusspray Htp, is a mast cell stabilizer presented as a nasal spray for nasal use. It treats allergic rhinitis and seasonal nasal allergy by reducing nasal congestion, itching, sneezing and watery discharge in affected individuals.

GNH USA supplies Natriumcromoglicaat Allergieneusspray Htp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to EU and other markets, ensuring product integrity.

Sodium cromoglicate nasal spray acts on mast cells to alleviate allergic nasal conditions.

Allergic rhinitis: reduces nasal congestion, itching, sneezing and rhinorrhea, improving daily comfort. Seasonal nasal allergy: provides symptom relief during pollen or mold exposure periods. Non‑allergic rhinitis with allergic component: may help control nasal symptoms when an allergic trigger is present.

Natriumcromoglicaat Allergieneusspray Htp may cause local and systemic adverse reactions, most of which are mild.

Common Side Effects: - Nasal irritation or burning sensation - Unpleasant taste or after‑taste - Mild headache - Throat dryness - Sneezing after administration - Cough

Serious or Rare Side Effects: - Epistaxis (nosebleed) - Severe hypersensitivity reaction including rash or angioedema - Anaphylactic shock - Nasal ulceration or perforation - Persistent nasal congestion unresponsive to treatment

Before using Natriumcromoglicaat Allergieneusspray Htp, consider the following precautions.

- Indication: Use only for allergic rhinitis or seasonal nasal allergy as prescribed. - Hypersensitivity: Do not use if you have known allergy to sodium cromoglicate or any excipients. - Age limitation: Pediatric use should follow local regulatory guidance; safety in young children is not established. - Concomitant nasal products: Avoid using other medicated nasal sprays simultaneously unless advised by a healthcare professional. - Asthma caution: Patients with asthma should monitor symptoms, as nasal irritation may affect lower airway. - Store at room temperature: Keep below 25 °C in the original packaging, protected from moisture and direct sunlight.

Sodium cromoglicate may interact with other medications administered via the nasal route or systemic agents affecting allergic pathways.

Major Interactions (Avoid): - Concurrent use with other mast cell stabilisers may increase local irritation without added benefit. - Use with nasal decongestant sprays containing oxymetazoline can potentiate mucosal dryness and risk of rebound congestion.

Moderate Interactions (Monitor Closely): - Combination with intranasal corticosteroids may enhance overall anti‑inflammatory effect; monitor for excessive dryness. - Co‑administration with first‑generation antihistamines may increase sedation; observe patient response. - Use with systemic antihistamines generally safe but may alter overall allergy control; adjust therapy as needed.